insights_auto
Why is GANX down 2,33%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
1,26 US$
arrow_downward
-2,33%(-0,030) 1D
1,32 US$
arrow_upward
+4,76% (+0,060)bedtimeAfter hours
Closed: 23 ოქტ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
1,33 US$
High
1,34 US$
Low
1,22 US$
Mkt. cap
54,99 მლნ.
Avg. vol.
560,84 ათ.
Volume
645,03 ათ.
52-wk high
4,34 US$
52-wk low
1,15 US$
EPS
-0,51 US$
Beta
0,19
Shares outstanding
43,64 მლნ.
No. of employees
21
Open
1,33 US$
High
1,34 US$
Low
1,22 US$
Mkt. cap
54,99 მლნ.
Avg. vol.
560,84 ათ.
Volume
645,03 ათ.
52-wk high
4,34 US$
52-wk low
1,15 US$
EPS
-0,51 US$
Beta
0,19
Shares outstanding
43,64 მლნ.
No. of employees
21
News stories
From web sources and news partners
Bloomberg.com
·
4 საათის წინ
Zero-Day Option Traders Are Betting Against Big S&P 500 Swings
Yahoo Finance
·
2 საათის წინ
Up 35%, How Long Can Coca-Cola Continue Crushing the S&P 500?
Stocktwits
·
5 საათის წინ
Apollo’s Torsten Slok Warns AI Has Delivered ‘Zero Financial Payoff’ Outside Tech — 'AI Story Will Be Decided In The S&P 493, Not The Mag 7'
Investor's Business Daily
·
2 საათის წინ
Futures Due; It's A Doom-And-Bloom Market
About Gain Therapeutics Inc